If only there was someone providing direct marketing and awareness to the public about the ability for this test to be taken up, we would see an uptake of the product in Australia.
Yet, google Febridx and bugger all in Australia will appear.
The way this is sold in Australia is that sale reps will have sales meetings with doctors / offices and pitch the product for use. The uptake is then dependent on that.
If the sales agents suck or the doctors don't see benefit, its not going to sell. It does not matter what kind of distribution channels you have.
The best thing Lumos could do is chat with the same Government teams they were dealing with for the RAT tests during Covid and work out a way to implement awareness of the product and its capabilities.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
7.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.64M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.3¢ | 74000 | 2 |
View Market Depth
| Last trade - 09.46am 01/08/2025 (20 minute delay) ? |
| LDX (ASX) Chart |
Day chart unavailable